newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics Presents Poster on the Identification of Mechanism of Action of CYT-0851 at the 34th Annual EORTC-NCI-AACR Symposium

- Poster details the research into CYT-0851 mechanism of action and identification as an inhibitor of monocarboxylate transporter activity Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT), a company focused on the